Tetracaine (TCN)
Amethocaine; Pontocaine; Ametop; Dicaine
Tetracaine is a potent local anesthetic of the ester group. It is mainly used topically in ophthalmology and as an antipruritic, and it has been used in spinal anesthesia. In biomedical research, tetracaine is used to alter the function of calcium release channels (ryanodine receptors) that control the release of calcium from intracellular stores. Tetracaine is an allosteric blocker of channel function. At low concentrations, tetracaine causes an initial inhibition of spontaneous calcium release events, while at high concentrations, tetracaine blocks release completely. Tetracaine is synthesized from 4-butylaminobenzoic acid. The ethyl ester is formed through an acid-catalyzed esterification reaction. Base-catalyzed transesterification is achieved by boiling the ethyl ester of 4-butylaminobenzoic acid with excess 2-dimethylaminoethanol in the presence of a small amount of sodium ethoxide.
Organism species: Pan-species (General)
- Customized Service n/a Complete Antigen of Tetracaine (TCN) Antigenic Transformation Customized Service Offer
- Customized Service n/a Monoclonal Antibody to Tetracaine (TCN) Monoclonal Antibody Customized Service Offer
- Customized Service n/a Polyclonal Antibody to Tetracaine (TCN) Polyclonal Antibody Customized Service Offer
- Customized Service n/a CLIA Kit for Tetracaine (TCN) CLIA Kit Customized Service Offer
- Customized Service n/a ELISA Kit for Tetracaine (TCN) ELISA Kit Customized Service Offer
